Suppr超能文献

种族和民族与美国肝硬化患者肝细胞癌、失代偿和死亡率的关联。

Associations of Race and Ethnicity with Hepatocellular Carcinoma, Decompensation, and Mortality in US Veterans with Cirrhosis.

机构信息

Epidemiology Program, Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington.

Department of Epidemiology, University of Washington, Seattle, Washington.

出版信息

Cancer Epidemiol Biomarkers Prev. 2023 Aug 1;32(8):1069-1078. doi: 10.1158/1055-9965.EPI-22-1291.

Abstract

BACKGROUND

Among patients with cirrhosis, it remains unclear whether there are racial/ethnic differences in cirrhosis complications and mortality. We examined the associations between race/ethnicity and risk for hepatocellular carcinoma (HCC), cirrhosis decompensation, and all-cause mortality overall and by cirrhosis etiology.

METHODS

US Veterans diagnosed with cirrhosis from 2001 to 2014 (n = 120,992), due to hepatitis C virus (HCV; n = 55,814), alcohol-associated liver disease (ALD; n = 36,323), hepatitis B virus (HBV; n = 1,972), nonalcoholic fatty liver disease (NAFLD; n = 17,789), or other (n = 9,094), were followed through 2020 for incident HCC (n = 10,242), cirrhosis decompensation (n = 27,887), and mortality (n = 81,441). Multivariable Cox proportional hazards regression was used to estimate adjusted hazard ratios (aHR) and 95% confidence intervals (CI).

RESULTS

Compared with non-Hispanic White patients, Hispanic patients had higher risk for HCC overall (aHR, 1.32; 95% CI, 1.24-1.41) and by cirrhosis etiology, particularly for ALD- (aHR, 1.63; 95% CI, 1.42-1.87) and NAFLD-cirrhosis (aHR, 1.76; 95% CI, 1.41-2.20), whereas non-Hispanic Black patients had lower HCC risk in ALD- (aHR, 0.79; 95% CI, 0.63-0.98) and NAFLD-cirrhosis (aHR, 0.54; 95% CI, 0.33-0.89). Asian patients had higher HCC risk (aHR, 1.70; 95% CI, 1.29-2.23), driven by HCV- and HBV-cirrhosis. Non-Hispanic Black patients had lower risk for cirrhosis decompensation overall (aHR, 0.71; 95% CI, 0.68-0.74) and by cirrhosis etiology. There was lower risk for mortality among all other racial/ethnic groups compared with non-Hispanic White patients.

CONCLUSIONS

Race/ethnicity is an important predictor for risk of developing HCC, decompensation, and mortality.

IMPACT

Future research should examine factors underlying these racial/ethnic differences to inform prevention, screening, and treatment for patients with cirrhosis.

摘要

背景

在肝硬化患者中,肝硬化并发症和死亡率是否存在种族/民族差异仍不清楚。我们研究了种族/民族与肝细胞癌(HCC)、肝硬化失代偿和全因死亡率之间的关系,以及按肝硬化病因进行的分层分析。

方法

我们对 2001 年至 2014 年间(n=120992)因丙型肝炎病毒(HCV;n=55814)、酒精性肝病(ALD;n=36323)、乙型肝炎病毒(HBV;n=1972)、非酒精性脂肪性肝病(NAFLD;n=17789)或其他原因(n=9094)导致肝硬化的美国退伍军人进行了研究,随访至 2020 年,以记录 HCC(n=10242)、肝硬化失代偿(n=27887)和死亡率(n=81441)的发生情况。采用多变量 Cox 比例风险回归模型估计调整后的风险比(aHR)和 95%置信区间(CI)。

结果

与非西班牙裔白人患者相比,西班牙裔患者总体上 HCC 风险更高(aHR,1.32;95%CI,1.24-1.41),且按肝硬化病因分层后,西班牙裔患者 HCC 风险更高,尤其是 ALD(aHR,1.63;95%CI,1.42-1.87)和 NAFLD 肝硬化(aHR,1.76;95%CI,1.41-2.20),而非西班牙裔黑人患者的 HCC 风险较低,ALD(aHR,0.79;95%CI,0.63-0.98)和 NAFLD 肝硬化(aHR,0.54;95%CI,0.33-0.89)。亚洲患者 HCC 风险较高(aHR,1.70;95%CI,1.29-2.23),主要由 HCV 和 HBV 引起。非西班牙裔黑人患者的肝硬化失代偿总风险较低(aHR,0.71;95%CI,0.68-0.74),且按肝硬化病因分层后也是如此。与非西班牙裔白人患者相比,所有其他种族/民族群体的死亡率均较低。

结论

种族/民族是发生 HCC、失代偿和死亡的重要预测因素。

意义

未来的研究应探讨导致这些种族/民族差异的因素,为肝硬化患者的预防、筛查和治疗提供信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b33/10390887/81ec1881c627/1069fig1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验